New SEC Form D filing

Linnaeus Therapeutics, Inc., 2026-11-18

A new SEC Form D private-offering notice from Haddonfield, NJ, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Linnaeus Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing GPER-targeted small molecule therapeutics for cancer, cardiometabolic disease and healthy aging

New filing yesterdayFiled to raise $10,000,000First money in 2026-11-16Raised so far $3,734,103HQ (as filed) Haddonfield, NJSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified linnaeustx.com↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source